Ventricular assist devices (VADs), among which the HeartMate 3 (HM3) is the latest clinically
approved representative, are often the therapy of choice for patients with end‐stage heart …

While earlier studies reported no relevant effect of the HeartMate 3 (HM3) artificial pulse
(AP) on bulk pump washout, its effect on regions with prolonged residence times remains …

Thrombosis and its related events have become a major concern during the development
and optimization of ventricular assist devices (VADs, also called blood pumps), and limit …

For those suffering from end-stage biventricular heart failure, and where a heart
transplantation is not a viable option, a Total Artificial Heart (TAH) can be used as a bridge to …

Purpose Due to the importance of public health and economics, cardiovascular disease has
become one of the most important debates and challenges for scientists. However, few …

Objective Mechanical circulatory support has become a standard therapy for adult patients
with end-stage heart failure. For pediatric patients, technologic development lags behind …

Numerical simulations of cardiac blood pump systems are integral to the optimization of
device design, hydraulic performance and hemocompatibility. In wave membrane blood …

The blood damage prediction in rotary blood pumps is an important procedure to evaluate
the hemocompatibility of such systems. Blood damage is caused by shear stresses to the …

Numerical flow simulations that analyze the turbulent flow characteristics within a turbopump
are important for optimizing the efficiency of such machines. In the case of ventricular assist …

Purpose Wave membrane blood pumps (WMBP) are novel pump designs in which blood is
propelled by means of wave propagation by an undulating membrane. In this paper, we …